IMPACT BIOMEDICINES, INC. logo

IMPACT BIOMEDICINES, INC.

6 Marks
Corp.
First Filed:Jul 13, 2015Latest Filed:Apr 24, 2020Address:86 Morris Avenue, Summit, NJ 07901

Portfolio Overview

Registered
2(33%)
Dead
4(67%)

Top Classes

Class 5
Pharmaceuticals
6(100%)

TTAB Proceedings

No litigation activity

Top Firms

BRISTOL-MYERS SQUIBB COMPANY(Apr 2020)
6

Trademark Portfolio

6 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
INREBIC
INREBIC
Trademark
Combined
ABANDONED
Owner:
Serial:88886318
Filed:Apr 24, 2020
Classes:5
INREBIC
INREBIC
Trademark
Combined
ABANDONED
Owner:
Serial:88886323
Filed:Apr 24, 2020
Classes:5
INREBIC
INREBIC
Trademark
Combined
REGISTERED
Owner:
Serial:88207119
Filed:Nov 27, 2018
Classes:5
Registration:5962898
Registered:Jan 14, 2020
Goods & Services
Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
REZNUVI
REZNUVI
Trademark
Word
ABANDONED
Owner:
Serial:87722685
Filed:Dec 15, 2017
Classes:5
ZELESPRA
ZELESPRA
Trademark
Word
ABANDONED
Owner:
Serial:87722697
Filed:Dec 15, 2017
Classes:5
INREBIC
INREBIC
Trademark
Word
REGISTERED
Owner:
Serial:86690908
Filed:Jul 13, 2015
Classes:5
Registration:4931750
Registered:Apr 5, 2016
Goods & Services
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, [ autoinflammatory disease, autoimmune disease, ] blood disease, cancer, [ arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; ] pharmaceutical preparations, namely, cytokine inhibitory drugs; [ pharmaceutical preparations that modulate the immune system ]

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.